Position in PFE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$59,296,142
+$18,824,205 QoQ
Shares Held
2,111,686
+29.9% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Mar 31, 2026CallValue
$56,160
CallShares
2,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CWM, LLC holds $807,852,719 across 18 Drug Manufacturers - General names. PFE ranks #6 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
692,270 | $169,218,478 | |
| 2 | LLY |
ELI LILLY & Co
|
144,076 | $132,516,782 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,010,525 | $121,556,052 | |
| 4 | ABBV |
AbbVie Inc.
|
464,400 | $101,002,356 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,256,734 | $76,220,917 | |
| 6 | PFE |
Pfizer Inc
This page
|
2,111,686 | $59,296,142 | |
| 7 | AMGN |
Amgen Inc
|
157,671 | $55,476,541 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
332,096 | $46,284,219 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $56,160 | 2,000 | Call | Sole | 2026-05-14 | |
| 2026-03-31 | $59,296,142 | 2,111,686 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $40,471,937 | 1,625,379 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $41,083,493 | 1,612,382 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $36,091,154 | 1,488,909 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $35,595,655 | 1,404,722 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $37,133,059 | 1,399,663 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $38,314,476 | 1,323,928 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $35,750,241 | 1,277,707 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $33,479,431 | 1,206,466 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $32,441,694 | 1,126,839 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $37,006,840 | 1,115,672 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $38,135,389 | 1,039,678 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $41,830,689 | 1,025,262 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $49,035,245 | 956,972 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $38,792,583 | 886,485 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $44,544,265 | 849,595 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $42,464,808 | 820,259 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $48,503,729 | 821,401 | Shares | Sole | 2022-01-31 | |
| 2021-06-30 | $35,925,188 | 917,395 | Shares | Sole | 2021-09-15 | |
| 2021-03-31 | $33,237,220 | 917,395 | Shares | Sole | 2021-09-15 | |
| 2020-12-31 | $33,769,309 | 917,395 | Shares | Sole | 2021-09-15 | |
| 2020-09-30 | $33,668,363 | 917,395 | Shares | Sole | 2021-09-15 | |
| 2020-06-30 | $29,998,847 | 917,395 | Shares | Sole | 2021-09-15 | |
| 2020-03-31 | $29,943,732 | 917,395 | Shares | Sole | 2021-09-15 | |
| No filing history on record for this holder in this stock. | ||||||